Dec 10 2009 |
more articles from
|
Jordan: Decline in cases continues; over 8,000 vaccinated - ministry
AMMAN - The Kingdom has posted its fifth consecutive decline in H1N1 (swine) flu cases, with one new fatality reported over the past week, a Ministry of Health report indicated on Wednesday.The ministry 's weekly swine flu update, issued yesterday, indicated that 25 H1N1 cases were registered between December 2 and 9, down from 29 cases between November 25 and December 2, and 87 the previous week.
The fatality, a 27-year-old man with no previous serious illnesses, raised the Kingdom's swine flu death toll to 15, according to the ministry .
Adel Bilbeisi, director of the ministry 's primary healthcare directorate, said the drop may indicate the end of the current "flu wave".
Bilbeisi also noted that the ministry is currently conducting 30-40 swine flu tests daily, compared to hundreds in previous months.
He added that all the new cases were Jordanians, with 28 per cent above the age of 30.
Around one-fourth of the patients in the past week were in the 20-24 age bracket, 24 per cent in the 25-29 age group, 16 per cent below the age of 10 and approximately 8 per cent aged between 10 and 19.
As of Wednesday, the total number of H1N1 cases reported in the Kingdom since the first case was recorded in June, stood at 3,009.
The report also indicated that 8,453 people categorised as high-risk have been inoculated since a vaccination campaign was launched last month.
According to Bilbeisi, no side effects have been reported among those who were vaccinated.
In order to curb the spread of swine flu, the ministry is currently vaccinating those categorised in high-risk groups.
These include 30,000 women in the third trimester of pregnancy, 310 patients suffering from kidney failure, children with type 1 diabetes, people with heart failure, an estimated 109 AIDS patients, some 1,200 thalassaemia patients and 10,000 patients with severe asthma.
In addition, the ministry has allocated 5,000 vaccines for medical staff that are in direct contact with swine flu patients, while some civil defence and public security personnel will also be inoculated.
The Health Ministry is purchasing two million vaccines from Novartis and 250,000 from Glaxo SmithKline, with one million doses to be delivered by the end of the year.
By Khetam Malkawi
© Jordan Times 2009
Zawya Comment Policy
-
Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse. - The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
- Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
- By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.
Copyright © 2012 Zawya Ltd. All rights reserved. |
provided by www.zawya.com |
Post Your Comment